Withdrawal Reactions Associated with Venlafaxine
@article{Parker1998WithdrawalRA, title={Withdrawal Reactions Associated with Venlafaxine}, author={Gordon Parker and Jenny Blennerhassett}, journal={Australian and New Zealand Journal of Psychiatry}, year={1998}, volume={32}, pages={291 - 294} }
Objective: The aim of this paper is to describe discontinuation syndromes associated with abrupt and tapered withdrawal of venlafaxine, and to document that withdrawal symptoms may occur after missing a single dose. Clinical picture: We report on two patients prescribed venlafaxine. One developed a broad range of serious side effects after reaching a dose of 300 mg a day, and a severe withdrawal syndrome (including hallucinations) during a slow taper regime. The second had severe…
34 Citations
Discontinuation Symptoms with Nefazodone
- MedicineThe Australian and New Zealand journal of psychiatry
- 1999
Nefazodone discontinuation can result in withdrawal symptoms and therefore needs to be tapered gradually, and those who have experienced discontinuation symptoms with other antidepressants in the past may be at increased risk.
Venlafaxine withdrawal syndrome.
- Medicine, PsychologyPsychiatria Danubina
- 2011
The case of a 70-year-old patient who discontinued of her own accord to take venlafaxine, which she had been taking regularly at a daily dose of 225 mg for more than a year, withdrawal syndrome occurred with severe symptoms resembling a stroke, and the patient fully recovered.
Venlafaxine and serious withdrawal symptoms: warning to drivers.
- Medicine, PsychologyMedGenMed : Medscape general medicine
- 2005
Clinical evidence about withdrawal symptoms is presented that may indicate incidents in noradrenergic activity irrespective of dosage, and patients are explicitly urged to adhere to a strict medication routine or not to drive a car.
Antidepressant Discontinuation Syndromes
- Medicine, PsychologyDrug safety
- 2001
Discontinuation symptoms have received little systematic study and most of the recommendations made here are based on anecdotal data or expert opinion, so research is needed to provide a firm evidence base for future recommendations.
Invited comment
- PsychologyActa psychiatrica Scandinavica
- 2009
A study examining the frequency of antidepressant discontinuation reactions by analysing calls to a psychiatric medication helpline found that the prevalence of withdrawal effects was the highest with venlafaxine and paroxetine.
Is There a Potential of Misuse for Venlafaxine and Bupropion?
- Medicine, PsychologyFront. Pharmacol.
- 2018
The dopaminergic, stimulant-like, bupropion activities may be associated with its possible recreational value and present data may confirm that the occurrence of a withdrawal syndrome may be a significant issue for venlafaxine-treated patients.
SELECTIVE SEROTONIN REUPTAKE INHIBITOR DISCONTINUATION SYNDROME : UNDERSTANDING, RECOGNITION, AND MANAGEMENT FOR PSYCHOLOGISTS
- Psychology, Medicine
- 1999
Psychologists increasingly provide psychotherapeutic services to patients receiving concomitanl pharmacotherapy and collaborate with physicians and other prescribing clinicians to prevent or manage the discontinuation syndrome.
Venlafaxine Extended-Release
- Medicine, PsychologyCNS drugs
- 2001
As an effective and well tolerated antidepressant, venlafaxine XR should be considered as a first-line pharmacological treatment in patients with major depression and was at least as effective as fluoxetine or parxetine and more effective than venl Lafaxine IR.
Prevention of the serotonin reuptake inhibitor discontinuation syndrome.
- MedicineMedical hypotheses
- 2002
Discontinuation symptoms: comparison of brief interruption in fluoxetine and paroxetine treatment
- Psychology, MedicineInternational clinical psychopharmacology
- 2002
The effects of shorter treatment interruption, as would occur if patients miss just a few doses of medication, on patients treated with fluoxetine appeared to be protected by its longer half-life, consistent with reports suggesting abrupt interruption of treatment with paroxetines is more often associated with somatic and psychological symptoms.
References
SHOWING 1-10 OF 12 REFERENCES
Serotonin reuptake inhibitor discontinuation syndrome: a hypothetical definition. Discontinuation Consensus panel.
- Psychology, MedicineThe Journal of clinical psychiatry
- 1997
A group of experts convened in Phoenix, Arizona, to develop a clear description or definition of the SRI discontinuation syndrome, which is distinctly different from the classic withdrawal syndrome associated with alcohol and barbiturates and may be minimized by slowly tapering antidepressant therapy.
Clinical management of antidepressant discontinuation.
- Psychology, MedicineThe Journal of clinical psychiatry
- 1997
To minimize the symptoms of antidepressant discontinuation, gradual tapering is necessary for all serotonin reuptake inhibitors (SRIs) except fluoxetine, which has an extended half-life. Agents with…
Serotonin reuptake inhibitor withdrawal.
- Psychology, MedicineJournal of clinical psychopharmacology
- 1996
Reports of withdrawal symptoms in a retrospective chart review of 352 patients treated in an outpatient clinic with the nonselective serotonin reuptake inhibitor clomipramine or with one of the selective SSRIs, fluoxetine, fluvoxamine, paroxettine, or sertraline suggest a role has been suggested for serotonin in coordinating sensory and autonomic function with motor activity.
A double‐blind comparison of venlafaxine and fluoxetine in patients hospitalized for major depression and melancholia
- Psychology, Medicine
- 1994
The antidepressant efficacy and short-term safety of venlafaxine and fluoxetine were compared in 68 patients hospitalized with major depression and melancholia and overall tolerance was similar for the two treatments.
The serotonin syndrome.
- Medicine, PsychologyThe American journal of psychiatry
- 1991
The serotonin syndrome is a toxic condition requiring heightened clinical awareness for prevention, recognition, and prompt treatment, and further work is needed to establish the diagnostic criteria, incidence, and predisposing factors.
Lithium-Induced Neurotoxicity at Serum Lithium Levels within the Therapeutic Range
- Medicine, PsychologyThe Australian and New Zealand journal of psychiatry
- 1996
Even when serum lithium levels are within the therapeutic range, lithium-induced neurotoxicity may occur, and patients on neuroleptics and the elderly in particular may be more vulnerable to these side effects.
Open treatment of obsessive-compulsive disorder with venlafaxine: a series of ten cases.
- PsychologyJournal of clinical psychopharmacology
- 1996
Venlafaxine Withdrawal Symptoms
- PsychologyCanadian journal of psychiatry. Revue canadienne de psychiatrie
- 1996